Oral bisphosphonate formulation used in treating bone density loss. Procured by hospitals, clinics, and pharmacies for endocrinologists and rheumatologists managing postmenopausal osteoporosis in patients over 50. Supplied by pharmaceutical manufacturers and distributed through wholesale networks to healthcare facilities.